These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7774046)

  • 1. Inhibition of gene expression by anti-sense oligodeoxynucleotides.
    Zheng RQ; Kemeny DM
    Clin Exp Immunol; 1995 Jun; 100(3):380-2. PubMed ID: 7774046
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene inhibition using antisense oligodeoxynucleotides.
    Wagner RW
    Nature; 1994 Nov; 372(6504):333-5. PubMed ID: 7969490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense gene inhibition by C-5-substituted deoxyuridine-containing oligodeoxynucleotides.
    Gutierrez AJ; Matteucci MD; Grant D; Matsumura S; Wagner RW; Froehler BC
    Biochemistry; 1997 Jan; 36(4):743-8. PubMed ID: 9020771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatitis B virus by antisense oligodeoxynucleotides.
    Blum HE; Galun E; von Weizsäcker F; Wands JR
    Lancet; 1991 May; 337(8751):1230. PubMed ID: 1673773
    [No Abstract]   [Full Text] [Related]  

  • 5. Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay.
    Seki M; Honda Y
    J Biochem; 1995 Dec; 118(6):1199-204. PubMed ID: 8720135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.
    Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI
    J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo inhibition of hepatitis B virus gene expression by antisense phosphorothioate oligonucleotides.
    Moriya K; Matsukura M; Kurokawa K; Koike K
    Biochem Biophys Res Commun; 1996 Jan; 218(1):217-23. PubMed ID: 8573134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oligodeoxynucleotides as anti-sense inhibitors of gene expression: therapeutic implications.
    Rothenberg M; Johnson G; Laughlin C; Green I; Cradock J; Sarver N; Cohen JS
    J Natl Cancer Inst; 1989 Oct; 81(20):1539-44. PubMed ID: 2677394
    [No Abstract]   [Full Text] [Related]  

  • 9. Antisense oligodeoxynucleotides targeted against different regions of cyclin D1 mRNA may exert different inhibitory effects on cell growth and gene expression.
    Hung WC; Huang JS; Chuang LY
    Biochem Biophys Res Commun; 1996 Mar; 220(3):719-23. PubMed ID: 8607831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does antisense make sense?
    Beijnen JH
    Pharm World Sci; 1993 Oct; 15(5):185. PubMed ID: 8257953
    [No Abstract]   [Full Text] [Related]  

  • 11. Sequence-specific inhibition of the tumor necrosis factor-alpha receptor I gene by oligodeoxynucleotides containing N7 modified 2'-deoxyguanosine.
    Ojwang JO; Lewis AF; Revankar GR; Walker D; Akiyama T; Hogan ME; Rando RF
    Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):447-59. PubMed ID: 9361904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence-specific inhibition of gene expression in intact human skin by epicutaneous application of chimeric antisense oligodeoxynucleotides.
    Wingens M; Pfundt R; van Vlijmen-Willems IM; van Hooijdonk CA; van Erp PE; Schalkwijk J
    Lab Invest; 1999 Nov; 79(11):1415-24. PubMed ID: 10576212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating cell signaling mechanisms using antisense technology.
    Koller E; Gaarde WA; Monia BP
    Trends Pharmacol Sci; 2000 Apr; 21(4):142-8. PubMed ID: 10740290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The state of the art in antisense research.
    Wagner RW
    Nat Med; 1995 Nov; 1(11):1116-8. PubMed ID: 7584973
    [No Abstract]   [Full Text] [Related]  

  • 15. Structure-activity relationships in cell culture.
    Wagner RW
    Ciba Found Symp; 1997; 209():142-54; discussion 154-7. PubMed ID: 9383574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy.
    Robinson GS; Pierce EA; Rook SL; Foley E; Webb R; Smith LE
    Proc Natl Acad Sci U S A; 1996 May; 93(10):4851-6. PubMed ID: 8643492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.
    Reed JC; Stein C; Subasinghe C; Haldar S; Croce CM; Yum S; Cohen J
    Cancer Res; 1990 Oct; 50(20):6565-70. PubMed ID: 2208117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent and selective gene inhibition using antisense oligodeoxynucleotides.
    Flanagan WM; Wagner RW
    Mol Cell Biochem; 1997 Jul; 172(1-2):213-25. PubMed ID: 9278247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA learns from antisense.
    Corey DR
    Nat Chem Biol; 2007 Jan; 3(1):8-11. PubMed ID: 17173018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of intercellular adhesion molecule-1 protein expression by antisense oligonucleotides is neuroprotective after transient middle cerebral artery occlusion in rat.
    Vemuganti R; Dempsey RJ; Bowen KK
    Stroke; 2004 Jan; 35(1):179-84. PubMed ID: 14657453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.